Extract from Half Yearly Report.
For the second half of the financial year, the Company will be focused on the following activities:
• Completion of detailed analyses from the Phase 2 HIV-1 clinical trial, locking of the trial database, unblinding and statistical analyses of the data, and release of results. • Continued testing of Biotron compounds for activity against other key commercially relevant virus targets. • Aiming to execute partnership agreement(s) for the Company’s antiviral programs in worldwide markets.
Extract from Half Yearly Report.For the second half of the...
-
- There are more pages in this discussion • 12,085 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.002(5.00%) |
Mkt cap ! $34.28M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 4.0¢ | 3.8¢ | $12.26K | 322.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 637000 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 175968 | 2 |
View Market Depth
| Last trade - 13.40pm 05/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |